Research Triangle Park, NC, July 23, 2018: The Carolina Longevity Institute LLC (CLI), announced that Michael Holder has joined as Chief Executive Officer and Portfolio Manager, effective June 6, 2018. CLI is an emerging portfolio of companies on a mission to extend human longevity and dramatically improve healthspan and quality of life during aging through innovative research and product offerings.
Holder, a seasoned executive with more than 30 years of experience, arrives at CLI with impressive credentials. Prior to joining CLI, he was the Chairman and CEO of Organ Transport Systems Inc., a medical technology company that is a leader in the organ preservation and transport industry. Holder has also held executive positions with a publicly traded hospital group purchasing organization, a leading enterprise software integration and technology firm, and a publicly traded provider of laser vision correction services. He has served as an executive with the Sam Walton family private equity fund and has been a board member for a number of public and private organizations. Holder holds an MBA from the Wharton School at the University of Pennsylvania and a B.S. in business administration from the Kenan-Flagler Business School at the University of North Carolina in Chapel Hill.
“Michael brings a combination of transactional, finance, scientific, and healthcare acumen to the table, and he is highly respected among the people he’s worked with over the years in many different contexts,” said CLI’s Chief Operations and Scientific Officer Brian Huber. “That combination is highly coveted and an increasing rarity.”
“The science of healthy aging and longevity is rapidly advancing,” added Huber. “Finding solutions directed at addressing the healthcare crisis in this country, including reducing healthcare spending, is in the best interest of the medical and business community and, ultimately, its consumers. If people can live longer and age healthier, that effort in itself will undeniably alleviate a significant portion of the burden on our congested healthcare system. My colleagues and I are inspired and honored to have Michael Holder at the helm as we collectively navigate this important frontier in longevity and healthspan.”
“All signs indicate that the time is ripe for the business of longevity and healthspan to flourish,” Holder said. “CLI is dedicated to – and taking strategic steps towards – being on the forefront of procuring and delivering effective scientific, medical and commercial solutions. Our passion and commitment to CLI’s mission is the cornerstone for making possible what was heretofore thought to be impossible with respect to making, not just significant strides, but truly giant leaps, in the longevity and healthspan fields. It is my honor and pleasure to be a part of this growing and outstanding team.”
About Carolina Longevity Institute
CLI’s mission is to significantly extend human life expectancy while simultaneously improving human healthspan (the number of years a person lives disease free). CLI is deploying resources nationally and internationally to carry out that mission on a number of fronts, including, but not limited to, investing in leading longevity therapy research and clinical trials. CLI is also building a portfolio of longevity and healthspan related companies in a variety of industries including, but not limited to, longevity clinics, supplements and nutraceuticals, genetics and precision medicine-related diagnostic labs, health products, artificial intelligence, and telemedicine in the U.S. and internationally.
Carolina Longevity Institute
Erin Masercola, Ph.D.
Source: Carolina Longevity Institute